Regulation of RIG-I-like receptor signaling by host and viral proteins

Cytokine and Growth Factor Reviews

Volumn 25, Issue 5, 2014, Pages 491-505

  Chiang, Jessica J ^a   Davis, Meredith E ^a   Gack, Michaela U ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Innate immunity; MDA5; RIG I; Type I interferon; Viral immune evasion

Indexed keywords

ADENOSINE TRIPHOSPHATE; MELANOMA DIFFERENTIATION-ASSOCIATED PROTEIN 5; MITOCHONDRIAL ANTIVIRAL SIGNALING PROTEIN; NONSTRUCTURAL PROTEIN 1; PATTERN RECOGNITION RECEPTOR; RETINOIC ACID INDUCIBLE PROTEIN I; RIG I LIKE RECEPTOR; UNCLASSIFIED DRUG; VIRUS PROTEIN; VIRUS PROTEIN V; DDX58 PROTEIN, HUMAN; DEAD BOX PROTEIN;

AUTOIMMUNE DISEASE; CORONAVIRUS; CYTOKINE RESPONSE; DNA VIRUS; FLAVIVIRUS; HERPES VIRUS; HUMAN; IMMUNE EVASION; INFLUENZA VIRUS A; INTERFERON INDUCTION; NONHUMAN; PARAMYXOVIRUS; PROTEIN CLEAVAGE; PROTEIN HYDROLYSIS; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; REVIEW; RNA VIRUS; SIGNAL TRANSDUCTION; UBIQUITINATION; VIRAL CLEARANCE; VIRUS INFECTION; VIRUS INHIBITION; ANIMAL; BIOLOGICAL MODEL; HOST PATHOGEN INTERACTION; INNATE IMMUNITY; METABOLISM; PHYSIOLOGY;

ANIMALS; DEAD-BOX RNA HELICASES; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, INNATE; MODELS, BIOLOGICAL; SIGNAL TRANSDUCTION; VIRAL PROTEINS;

EID: 84908330408     PISSN: 13596101     EISSN: 18790305     Source Type: Journal    
DOI: 10.1016/j.cytogfr.2014.06.005     Document Type: Review

References (164)

1. Takeuchi O., Akira S. Pattern recognition receptors and inflammation. Cell 2010, 140:805-820.
2. Yoneyama M., Kikuchi M., Natsukawa T., Shinobu N., Imaizumi T., Miyagishi M., et al. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol 2004, 5:730-737.
3. Andrejeva J., Childs K.S., Young D.F., Carlos T.S., Stock N., Goodbourn S., et al. The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFN-beta promoter. Proc Natl Acad Sci USA 2004, 101:17264-17269.
4. Rothenfusser S., Goutagny N., DiPerna G., Gong M., Monks B.G., Schoenemeyer A., et al. The RNA helicase Lgp2 inhibits TLR-independent sensing of viral replication by retinoic acid-inducible gene-I. J Immunol 2005, 175:5260-5268.
5. Kato H., Sato S., Yoneyama M., Yamamoto M., Uematsu S., Matsui K., et al. Cell type-specific involvement of RIG-I in antiviral response. Immunity 2005, 23:19-28.
6. Kowalinski E., Lunardi T., McCarthy A., Louber J., Brunel J., Grigorov B., et al. Structural basis for the activation of innate immune pattern-recognition receptor RIG-I by viral RNA. Cell 2011, 147:423-435.
7. Luo D., Ding S.C., Vela A., Kohlway A., Lindenbach B.D., Pyle A.M. Structural insights into RNA recognition by RIG-I. Cell 2011, 147:409-422.
8. Belgnaoui S., Paz S., Hiscott J. Orchestrating the interferon antiviral response through the mitochondrial antiviral signaling (MAVS) adapter. Curr Opin Immunol 2011, 23:564-572.
9. Bruns A.M., Horvath C.M. Activation of RIG-I-like receptor signal transduction. Crit Rev Biochem Mol Biol 2012, 47:194-206.
10. Venkataraman T., Valdes M., Elsby R., Kakuta S., Caceres G., Saijo S., et al. Loss of DExD/H box RNA helicase LGP2 manifests disparate antiviral responses. J Immunol 2007, 178:6444-6455.
11. Satoh T., Kato H., Kumagai Y., Yoneyama M., Sato S., Matsushita K., et al. LGP2 is a positive regulator of RIG-I- and MDA5-mediated antiviral responses. Proc Natl Acad Sci USA 2010, 107:1512-1517.
12. Seth R., Sun L., Ea C.-K., Chen Z. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell 2005, 122:669-682.
13. Meylan E., Curran J., Hofmann K., Moradpour D., Binder M., Bartenschlager R., et al. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 2005, 437:1167-1172.
14. Xu L.-G., Wang Y.-Y., Han K.-J., Li L.-Y., Zhai Z., Shu H.-B. VISA is an adapter protein required for virus-triggered IFN-beta signaling. Mol Cell 2005, 19:727-740.
15. Kawai T., Takahashi K., Sato S., Coban C., Kumar H., Kato H., et al. IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat Immunol 2005, 6:981-988.
16. Dixit E., Boulant S., Zhang Y., Lee A., Odendall C., Shum B., et al. Peroxisomes are signaling platforms for antiviral innate immunity. Cell 2010, 141:668-681.
17. Horner S.M., Liu H.M., Park H.S., Briley J., Gale M. Mitochondrial-associated endoplasmic reticulum membranes (MAM) form innate immune synapses and are targeted by hepatitis C virus. Proc Natl Acad Sci USA 2011, 108:14590-14595.
18. West A., Shadel G., Ghosh S. Mitochondria in innate immune responses. Nat Rev Immunol 2011, 11:389-402.
19. Ishikawa H., Ma Z., Barber G.N. STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity. Nature 2009, 461:788-792.
20. Ishikawa H., Barber G.N. STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling. Nature 2008, 455:674-678.
21. Zhong B., Yang Y., Li S., Wang Y.Y., Li Y., Diao F., et al. The adaptor protein MITA links virus-sensing receptors to IRF3 transcription factor activation. Immunity 2008, 29:538-550.
22. Hou F., Sun L., Zheng H., Skaug B., Jiang Q.X., Chen Z.J. MAVS forms functional prion-like aggregates to activate and propagate antiviral innate immune response. Cell 2011, 146:448-461.
23. Goubau D., Deddouche S., Reis e Sousa C. Cytosolic sensing of viruses. Immunity 2013, 38:855-869.
24. Schlee M. Master sensors of pathogenic RNA - RIG-I like receptors. Immunobiology 2013, 218:1322-1335.
25. Saito T., Owen D.M., Jiang F., Marcotrigiano J., Gale M. Innate immunity induced by composition-dependent RIG-I recognition of hepatitis C virus RNA. Nature 2008, 454:523-527.
26. Uzri D., Gehrke L. Nucleotide sequences and modifications that determine RIG-I/RNA binding and signaling activities. J Virol 2009, 83:4174-4184.
27. Cui S., Eisenacher K., Kirchhofer A., Brzozka K., Lammens A., Lammens K., et al. The C-terminal regulatory domain is the RNA 5'-triphosphate sensor of RIG-I. Mol Cell 2008, 29:169-179.
28. Takahasi K., Yoneyama M., Nishihori T., Hirai R., Kumeta H., Narita R., et al. Nonself RNA-sensing mechanism of RIG-I helicase and activation of antiviral immune responses. Mol Cell 2008, 29:428-440.
29. Chiu Y.H., Macmillan J.B., Chen Z.J. RNA polymerase III detects cytosolic DNA and induces type I interferons through the RIG-I pathway. Cell 2009, 138:576-591.
30. Ablasser A., Bauernfeind F., Hartmann G., Latz E., Fitzgerald K.A., Hornung V. RIG-I-dependent sensing of poly(dA:dT) through the induction of an RNA polymerase III-transcribed RNA intermediate. Nat Immunol 2009, 10:1065-1072.
31. Minamitani T., Iwakiri D., Takada K. Adenovirus virus-associated RNAs induce type I interferon expression through a RIG-I-mediated pathway. J Virol 2011, 85:4035-4040.
32. Pichlmair A., Schulz O., Tan C.-P., Rehwinkel J., Kato H., Takeuchi O., et al. Activation of MDA5 requires higher-order RNA structures generated during virus infection. J Virol 2009, 10761-10769.
33. Kato H., Takeuchi O., Mikamo-Satoh E., Hirai R., Kawai T., Matsushita K., et al. Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid-inducible gene-I and melanoma differentiation-associated gene 5. J Exp Med 2008, 205:1601-1610.
34. Peisley A., Lin C., Wu B., Orme-Johnson M., Liu M., Walz T., et al. Cooperative assembly and dynamic disassembly of MDA5 filaments for viral dsRNA recognition. Proc Natl Acad Sci USA 2011, 108:21010-21015.
35. Feng Q., Hato S.V., Langereis M.A., Zoll J., Virgen-Slane R., Peisley A., et al. MDA5 detects the double-stranded RNA replicative form in picornavirus-infected cells. Cell Rep 2012, 2:1187-1196.
36. Peisley A., Jo M.H., Lin C., Wu B., Orme-Johnson M., Walz T., et al. Kinetic mechanism for viral dsRNA length discrimination by MDA5 filaments. Proc Natl Acad Sci USA 2012, 109:E3340-E3349.
37. Berke I., Yu X., Modis Y., Egelman E. MDA5 assembles into a polar helical filament on dsRNA. Proc Natl Acad Sci USA 2012, 109:18437-18441.
38. Zust R., Cervantes-Barragan L., Habjan M., Maier R., Neuman B.W., Ziebuhr J., et al. Ribose 2'-O-methylation provides a molecular signature for the distinction of self and non-self mRNA dependent on the RNA sensor Mda5. Nat Immunol 2011, 12:137-143.
39. Gitlin L., Barchet W., Gilfillan S., Cella M., Beutler B., Flavell R., et al. Essential role of mda-5 in type I IFN responses to polyriboinosinic:polyribocytidylic acid and encephalomyocarditis picornavirus. Proc Natl Acad Sci USA 2006, 103:8459-8464.
40. Kato H., Takeuchi O., Sato S., Yoneyama M., Yamamoto M., Matsui K., et al. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 2006, 441:101-105.
41. Loo Y.-M., Gale M. Immune signaling by RIG-I-like receptors. Immunity 2011, 34:680-692.
42. Gitlin L., Benoit L., Song C., Cella M., Gilfillan S., Holtzman M., et al. Melanoma differentiation-associated gene 5 (MDA5) is involved in the innate immune response to Paramyxoviridae infection in vivo. PLoS Pathog 2010, 6.
43. Ikegame S., Takeda M., Ohno S., Nakatsu Y., Nakanishi Y., Yanagi Y. Both RIG-I and MDA5 RNA helicases contribute to the induction of alpha/beta interferon in measles virus-infected human cells. J Virol 2010, 84:372-379.
44. Runge S., Sparrer K.M.J., Lässig C., Hembach K., Baum A., García-Sastre A., et al. In vivo ligands of MDA5 and RIG-I in measles virus-infected cells. PLoS Pathog 2014, 10.
45. Baum A., Sachidanandam R., Garcia-Sastre A. Preference of RIG-I for short viral RNA molecules in infected cells revealed by next-generation sequencing. Proc Natl Acad Sci USA 2010, 16303-16308.
46. Weber M., Gawanbacht A., Habjan M., Rang A., Borner C., Schmidt A.M., et al. Incoming RNA virus nucleocapsids containing a 5'-triphosphorylated genome activate RIG-I and antiviral signaling. Cell Host Microbe 2013, 13:336-346.
47. Fredericksen B., Keller B., Fornek J., Katze M., Gale M. Establishment and maintenance of the innate antiviral response to West Nile Virus involves both RIG-I and MDA5 signaling through IPS-1. J Virol 2008, 82:609-616.
48. Errett J., Suthar M., McMillan A., Diamond M., Gale M. The essential, nonredundant roles of RIG-I and MDA5 in detecting and controlling West Nile Virus infection. J Virol 2013, 87:11416-11425.
49. Saito T., Hirai R., Loo Y.M., Owen D., Johnson C.L., Sinha S.C., et al. Regulation of innate antiviral defenses through a shared repressor domain in RIG-I and LGP2. Proc Natl Acad Sci USA 2007, 104:582-587.
50. Gack M.U. Mechanisms of RIG-I-like receptor activation and manipulation by viral pathogens. J Virol 2014, 88:5213-5216.
51. Sun Z., Ren H., Liu Y., Teeling J.L., Gu J. Phosphorylation of RIG-I by casein kinase II inhibits its antiviral response. J Virol 2010, 85.
52. Gack M., Nistal-Villán E., Inn K.-S., García-Sastre A., Jung J. Phosphorylation-mediated negative regulation of RIG-I antiviral activity. J Virol 2010, 84:3220-3229.
53. Maharaj N.P., Wies E., Stoll A., Gack M.U. Conventional protein kinase C-alpha (PKC-alpha) and PKC-beta negatively regulate RIG-I antiviral signal transduction. J Virol 2012, 86:1358-1371.
54. Nistal-Villan E., Gack M.U., Martinez-Delgado G., Maharaj N.P., Inn K.S., Yang H., et al. Negative role of RIG-I serine 8 phosphorylation in the regulation of interferon-beta production. J Biol Chem 2010, 285:20252-20261.
55. Kohlway A., Luo D., Rawling D.C., Ding S.C., Pyle A.M. Defining the functional determinants for RNA surveillance by RIG-I. EMBO Rep 2013, 14:772-779.
56. Lu C., Xu H., Ranjith-Kumar C.T., Brooks M.T., Hou T.Y., Hu F., et al. The structural basis of 5' triphosphate double-stranded RNA recognition by RIG-I C-terminal domain. Structure 2010, 18:1032-1043.
57. Wang Y., Ludwig J., Schuberth C., Goldeck M., Schlee M., Li H., et al. Structural and functional insights into 5'-ppp RNA pattern recognition by the innate immune receptor RIG-I. Nat Struct Mol Biol 2010, 17:781-787.
58. Vela A., Fedorova O., Ding S.C., Pyle A.M. The thermodynamic basis for viral RNA detection by the RIG-I innate immune sensor. J Biol Chem 2012, 287:42564-42573.
59. Wies E., Wang M., Maharaj N., Chen K., Zhou S., Finberg R., et al. Dephosphorylation of the RNA sensors RIG-I and MDA5 by the phosphatase PP1 is essential for innate immune signaling. Immunity 2013, 38:437-449.
60. Cohen P.T. Protein phosphatase 1 - targeted in many directions. J Cell Sci 2002, 115:241-256.
61. Weissman A.M. Themes and variations on ubiquitylation. Nat Rev Mol Cell Biol 2001, 2:169-178.
62. Gack M., Shin Y., Joo C.-H., Urano T., Liang C., Sun L., et al. TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity. Nature 2007, 446:916-920.
63. Rajsbaum R., Garcia-Sastre A., Versteeg G.A. TRIMmunity: the roles of the TRIM E3-ubiquitin ligase family in innate antiviral immunity. J Mol Biol 2014, 426:1265-1284.
64. Versteeg G.A., Rajsbaum R., Sanchez-Aparicio M.T., Maestre A.M., Valdiviezo J., Shi M., et al. The E3-ligase TRIM family of proteins regulates signaling pathways triggered by innate immune pattern-recognition receptors. Immunity 2013, 38:384-398.
65. Gack M., Kirchhofer A., Shin Y., Inn K.-S., Liang C., Cui S., et al. Roles of RIG-I N-terminal tandem CARD and splice variant in TRIM25-mediated antiviral signal transduction. Proc Natl Acad Sci USA 2008, 105:16743-16748.
66. Oshiumi H., Matsumoto M., Hatakeyama S., Seya T. Riplet/RNF135, a RING finger protein, ubiquitinates RIG-I to promote interferon-beta induction during the early phase of viral infection. J Biol Chem 2009, 284:807-817.
67. Oshiumi H., Miyashita M., Inoue N., Okabe M., Matsumoto M., Seya T. The ubiquitin ligase Riplet is essential for RIG-I-dependent innate immune responses to RNA virus infection. Cell Host Microbe 2010, 8:496-509.
68. Oshiumi H., Miyashita M., Matsumoto M., Seya T. A distinct role of Riplet-mediated K63-Linked polyubiquitination of the RIG-I repressor domain in human antiviral innate immune responses. PLoS Pathog 2013, 9:e1003533.
69. Friedman C.S., O'Donnell M.A., Legarda-Addison D., Ng A., Cardenas W.B., Yount J.S., et al. The tumour suppressor CYLD is a negative regulator of RIG-I-mediated antiviral response. EMBO Rep 2008, 9:930-936.
70. Cui J., Song Y., Li Y., Zhu Q., Tan P., Qin Y., et al. USP3 inhibits type I interferon signaling by deubiquitinating RIG-I-like receptors. Cell Res 2014, 24:400-416.
71. Fan Y., Mao R., Yu Y., Liu S., Shi Z., Cheng J., et al. USP21 negatively regulates antiviral response by acting as a RIG-I deubiquitinase. J Exp Med 2014, 211:313-328.
72. Wang P., Arjona A., Zhang Y., Sultana H., Dai J., Yang L., et al. Caspase-12 controls West Nile virus infection via the viral RNA receptor RIG-I. Nat Immunol 2010, 11:912-919.
73. Zeng W., Sun L., Jiang X., Chen X., Hou F., Adhikari A., et al. Reconstitution of the RIG-I pathway reveals a signaling role of unanchored polyubiquitin chains in innate immunity. Cell 2010, 141:315-330.
74. Jiang X., Kinch L., Brautigam C., Chen X., Du F., Grishin N., et al. Ubiquitin-induced oligomerization of the RNA sensors RIG-I and MDA5 activates antiviral innate immune response. Immunity 2012, 36:959-973.
75. Peisley A., Wu B., Xu H., Chen Z.J., Hur S. Structural basis for ubiquitin-mediated antiviral signal activation by RIG-I. Nature 2014, 509:110-114.
76. Liu H., Loo Y.-M., Horner S., Zornetzer G., Katze M., Gale M. The mitochondrial targeting chaperone 14-3-3e regulates a RIG-I translocon that mediates membrane association and innate antiviral immunity. Cell Host Microbe 2012, 11:528-537.
77. Arimoto K., Takahashi H., Hishiki T., Konishi H., Fujita T., Shimotohno K. Negative regulation of the RIG-I signaling by the ubiquitin ligase RNF125. Proc Natl Acad Sci USA 2007, 104:7500-7505.
78. Lin R., Yang L., Nakhaei P., Sun Q., Sharif-Askari E., Julkunen I., et al. Negative regulation of the retinoic acid-inducible gene I-induced antiviral state by the ubiquitin-editing protein A20. J Biol Chem 2006, 281:2095-2103.
79. Wang L., Zhao W., Zhang M., Wang P., Zhao K., Zhao X., et al. USP4 positively regulates RIG-I-mediated antiviral response through deubiquitination and stabilization of RIG-I. J Virol 2013, 87:4507-4515.
80. Inn K.S., Gack M.U., Tokunaga F., Shi M., Wong L.Y., Iwai K., et al. Linear ubiquitin assembly complex negatively regulates RIG-I- and TRIM25-mediated type I interferon induction. Mol Cell 2011, 41:354-365.
81. Pauli E.K., Chan Y.K., Davis M.E., Gableske S., Wang M.K., Feister K.F., et al. The ubiquitin-specific protease USP15 promotes RIG-I-mediated antiviral signaling by deubiquitylating TRIM25. Sci Signal 2014, 7:ra3.
82. Berke I., Modis Y. MDA5 cooperatively forms dimers and ATP-sensitive filaments upon binding double-stranded RNA. EMBO J 2012, 31:1714-1726.
83. Wu B., Peisley A., Richards C., Yao H., Zeng X., Lin C., et al. Structural basis for dsRNA recognition, filament formation, and antiviral signal activation by MDA5. Cell 2013, 152:276-289.
84. Diao F., Li S., Tian Y., Zhang M., Xu L.G., Zhang Y., et al. Negative regulation of MDA5- but not RIG-I-mediated innate antiviral signaling by the dihydroxyacetone kinase. Proc Natl Acad Sci USA 2007, 104:11706-11711.
85. Fu J., Xiong Y., Xu Y., Cheng G., Tang H. MDA5 is SUMOylated by PIAS2β in the upregulation of type I interferon signaling. Mol Immunol 2011, 48:415-422.
86. Chen H., Li Y., Zhang J., Ran Y., Wei J., Yang Y., et al. RAVER1 is a coactivator of MDA5-mediated cellular antiviral response. J Mol Cell Biol 2013, 5:111-119.
87. Moore C., Bergstralh D., Duncan J., Lei Y., Morrison T., Zimmermann A., et al. NLRX1 is a regulator of mitochondrial antiviral immunity. Nature 2008, 451:573-577.
88. Arnoult D., Soares F., Tattoli I., Castanier C., Philpott D., Girardin S. An N-terminal addressing sequence targets NLRX1 to the mitochondrial matrix. J Cell Sci 2009, 122:3161-3168.
89. Tattoli I., Carneiro L., Jéhanno M., Magalhaes J., Shu Y., Philpott D., et al. NLRX1 is a mitochondrial NOD-like receptor that amplifies NF-kappaB and JNK pathways by inducing reactive oxygen species production. EMBO Rep 2008, 9:293-300.
90. Soares F., Tattoli I., Wortzman M.E., Arnoult D., Philpott D.J., Girardin S.E. NLRX1 does not inhibit MAVS-dependent antiviral signalling. Innate Immun 2013, 19:438-448.
91. Allen I., Moore C., Schneider M., Lei Y., Davis B., Scull M., et al. NLRX1 protein attenuates inflammatory responses to infection by interfering with the RIG-I-MAVS and TRAF6-NF-κB signaling pathways. Immunity 2011, 34:854-865.
92. Rebsamen M., Vazquez J., Tardivel A., Guarda G., Curran J., Tschopp J. NLRX1/NOD5 deficiency does not affect MAVS signalling. Cell Death Differ 2011, 18:1387.
93. Lei Y., Wen H., Yu Y., Taxman D.J., Zhang L., Widman D.G., et al. The mitochondrial proteins NLRX1 and TUFM form a complex that regulates type I interferon and autophagy. Immunity 2012, 36:933-946.
94. Yasukawa K., Oshiumi H., Takeda M., Ishihara N., Yanagi Y., Seya T., et al. Mitofusin 2 inhibits mitochondrial antiviral signaling. Sci Signal 2009, 2:ra47.
95. Xu L., Xiao N., Liu F., Ren H., Gu J. Inhibition of RIG-I and MDA5-dependent antiviral response by gC1qR at mitochondria. Proc Natl Acad Sci USA 2009, 106:1530-1535.
96. Jounai N., Takeshita F., Kobiyama K., Sawano A., Miyawaki A., Xin K.Q., et al. The Atg5 Atg12 conjugate associates with innate antiviral immune responses. Proc Natl Acad Sci USA 2007, 104:14050-14055.
97. Li M.T., Di W., Xu H., Yang Y.K., Chen H.W., Zhang F.X., et al. Negative regulation of RIG-I-mediated innate antiviral signaling by SEC14L1. J Virol 2013, 87:10037-10046.
98. Cui J., Zhu L., Xia X., Wang H.Y., Legras X., Hong J., et al. NLRC5 negatively regulates the NF-kappaB and type I interferon signaling pathways. Cell 2010, 141:483-496.
99. Wang P., Yang L., Cheng G., Yang G., Xu Z., You F., et al. UBXN1 interferes with Rig-I-like receptor-mediated antiviral immune response by targeting MAVS. Cell Rep 2013, 3:1057-1070.
100. Lad S.P., Yang G., Scott D.A., Chao T.H., Correia Jda S., de la Torre J.C., et al. Identification of MAVS splicing variants that interfere with RIGI/MAVS pathway signaling. Mol Immunol 2008, 45:2277-2287.
101. Brubaker S.W., Gauthier A.E., Mills E.W., Ingolia N.T., Kagan J.C. A bicistronic MAVS transcript highlights a class of truncated variants in antiviral immunity. Cell 2014, 156:800-811.
102. You F., Sun H., Zhou X., Sun W., Liang S., Zhai Z., et al. PCBP2 mediates degradation of the adaptor MAVS via the HECT ubiquitin ligase AIP4. Nat Immunol 2009, 10:1300-1308.
103. Wang Y., Tong X., Ye X. Ndfip1 negatively regulates RIG-I-dependent immune signaling by enhancing E3 ligase Smurf1-mediated MAVS degradation. J Immunol 2012, 189:5304-5313.
104. Zhong B., Zhang Y., Tan B., Liu T.T., Wang Y.Y., Shu H.B. The E3 ubiquitin ligase RNF5 targets virus-induced signaling adaptor for ubiquitination and degradation. J Immunol 2010, 184:6249-6255.
105. Castanier C., Garcin D., Vazquez A., Arnoult D. Mitochondrial dynamics regulate the RIG-I-like receptor antiviral pathway. EMBO Rep 2010, 11:133-138.
106. Zhao Y., Sun X., Nie X., Sun L., Tang T.S., Chen D., et al. COX5B regulates MAVS-mediated antiviral signaling through interaction with ATG5 and repressing ROS production. PLoS Pathog 2012, 8:e1003086.
107. Koshiba T., Yasukawa K., Yanagi Y., Kawabata S. Mitochondrial membrane potential is required for MAVS-mediated antiviral signaling. Sci Signal 2011, 4:ra7.
108. Bozym R., Delorme-Axford E., Harris K., Morosky S., Ikizler M., Dermody T., et al. Focal adhesion kinase is a component of antiviral RIG-I-like receptor signaling. Cell Host Microbe 2012, 11:153-166.
109. Bowie A., Unterholzner L. Viral evasion and subversion of pattern-recognition receptor signalling. Nat Rev Immunol 2008, 8:911-922.
110. García-Sastre A. Induction and evasion of type I interferon responses by influenza viruses. Virus Res 2011, 162:12-18.
111. Gack M., Albrecht R., Urano T., Inn K.-S., Huang I.C., Carnero E., et al. Influenza A virus NS1 targets the ubiquitin ligase TRIM25 to evade recognition by the host viral RNA sensor RIG-I. Cell Host Microbe 2009, 5:439-449.
112. Rajsbaum R., Albrecht R., Wang M., Maharaj N., Versteeg G., Nistal-Villán E., et al. Species-specific inhibition of RIG-I ubiquitination and IFN induction by the influenza A virus NS1 protein. PLoS Pathog 2012, 8.
113. González C., Wang L., Damania B. Kaposi's sarcoma-associated herpesvirus encodes a viral deubiquitinase. J Virol 2009, 83:10224-10233.
114. Inn K.-S., Lee S.-H., Rathbun J., Wong L.-Y., Toth Z., Machida K., et al. Inhibition of RIG-I-mediated signaling by Kaposi's sarcoma-associated herpesvirus-encoded deubiquitinase ORF64. J Virol 2011, 85:10899-10904.
115. Barretto N., Jukneliene D., Ratia K., Chen Z., Mesecar A., Baker S. The papain-like protease of severe acute respiratory syndrome coronavirus has deubiquitinating activity. J Virol 2005, 79:15189-15198.
116. Ratia K., Saikatendu K., Santarsiero B., Barretto N., Baker S., Stevens R., et al. Severe acute respiratory syndrome coronavirus papain-like protease: structure of a viral deubiquitinating enzyme. Proc Natl Acad Sci USA 2006, 103:5717-5722.
117. Devaraj S., Wang N., Chen Z., Chen Z., Tseng M., Barretto N., et al. Regulation of IRF-3-dependent innate immunity by the papain-like protease domain of the severe acute respiratory syndrome coronavirus. J Biol Chem 2007, 282:32208-32221.
118. Clementz M., Chen Z., Banach B., Wang Y., Sun L., Ratia K., et al. Deubiquitinating and interferon antagonism activities of coronavirus papain-like proteases. J Virol 2010, 84:4619-4629.
119. Sun L., Xing Y., Chen X., Zheng Y., Yang Y., Nichols D., et al. Coronavirus papain-like proteases negatively regulate antiviral innate immune response through disruption of STING-mediated signaling. PLoS One 2012, 7.
120. de Los Santos T., de Avila Botton S., Weiblen R., Grubman M. The leader proteinase of foot-and-mouth disease virus inhibits the induction of beta interferon mRNA and blocks the host innate immune response. J Virol 2006, 80:1906-1914.
121. Hato S., Sorgeloos F., Ricour C., Zoll J., Melchers W., Michiels T., et al. Differential IFN-alpha/beta production suppressing capacities of the leader proteins of mengovirus and foot-and-mouth disease virus. Cell Microbiol 2010, 12:310-317.
122. Wang D., Fang L., Li P., Sun L., Fan J., Zhang Q., et al. The leader proteinase of foot-and-mouth disease virus negatively regulates the type I interferon pathway by acting as a viral deubiquitinase. J Virol 2011, 85:3758-3766.
123. Frias-Staheli N., Giannakopoulos N., Kikkert M., Taylor S., Bridgen A., Paragas J., et al. Ovarian tumor domain-containing viral proteases evade ubiquitin- and ISG15-dependent innate immune responses. Cell Host Microbe 2007, 2:404-416.
124. Capodagli G., McKercher M., Baker E., Masters E., Brunzelle J., Pegan S. Structural analysis of a viral ovarian tumor domain protease from the Crimean-Congo hemorrhagic fever virus in complex with covalently bonded ubiquitin. J Virol 2011, 85:3621-3630.
125. van Kasteren P., Beugeling C., Ninaber D., Frias-Staheli N., van Boheemen S., García-Sastre A., et al. Arterivirus and nairovirus ovarian tumor domain-containing Deubiquitinases target activated RIG-I to control innate immune signaling. J Virol 2012, 86:773-785.
126. Goodbourn S.R. The regulation of type I interferon production by paramyxoviruses. J Interferon Cytokine Res 2009.
127. Childs K., Stock N., Ross C., Andrejeva J., Hilton L., Skinner M., et al. mda-5, but not RIG-I, is a common target for paramyxovirus V proteins. Virology 2007, 359:190-200.
128. Parisien J.-P., Bamming D., Komuro A., Ramachandran A., Rodriguez J., Barber G., et al. A shared interface mediates paramyxovirus interference with antiviral RNA helicases MDA5 and LGP2. J Virol 2009, 83:7252-7260.
129. Childs K., Andrejeva J., Randall R., Goodbourn S. Mechanism of mda-5 Inhibition by paramyxovirus V proteins. J Virol 2009, 83:1465-1473.
130. Rodriguez K., Horvath C. Amino acid requirements for MDA5 and LGP2 recognition by paramyxovirus V proteins: a single arginine distinguishes MDA5 from RIG-I. J Virol 2013, 87:2974-2978.
131. Horvath C. Silencing STATs: lessons from paramyxovirus interferon evasion. Cytokine Growth Factor Rev 2004, 15:117127.
132. Motz C., Schuhmann K., Kirchhofer A., Moldt M., Witte G., Conzelmann K.-K., et al. Paramyxovirus V proteins disrupt the fold of the RNA sensor MDA5 to inhibit antiviral signaling. Science (New York, NY) 2013, 339:690-693.
133. Kok K.-H., Lui P.-Y., Ng M-HJ, Siu K.-L., Au S., Jin D.-Y. The double-stranded RNA-binding protein PACT functions as a cellular activator of RIG-I to facilitate innate antiviral response. Cell Host Microbe 2011, 9:299-309.
134. Luthra P., Ramanan P., Mire C., Weisend C., Tsuda Y., Yen B., et al. Mutual antagonism between the Ebola virus VP35 protein and the RIG-I activator PACT determines infection outcome. Cell Host Microbe 2013, 14:74-84.
135. Zielecki F., Weber M., Eickmann M., Spiegelberg L., Zaki A., Matrosovich M., et al. Human cell tropism and innate immune system interactions of human respiratory coronavirus EMC compared to those of severe acute respiratory syndrome coronavirus. J Virol 2013, 87:5300-5304.
136. Chan R., Chan M., Agnihothram S., Chan L., Kuok D., Fong J., et al. Tropism of and innate immune responses to the novel human betacoronavirus lineage C virus in human ex vivo respiratory organ cultures. J Virol 2013, 87:6604-6614.
137. Falzarano D., de Wit E., Rasmussen A., Feldmann F., Okumura A., Scott D., et al. Treatment with interferon-(2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques. Nat Med 2013, 19:1313-1317.
138. Zhou J., Chu H., Li C., Wong B., Cheng Z.-S., Poon V., et al. Active replication of middle East respiratory syndrome coronavirus and aberrant induction of inflammatory cytokines and chemokines in human macrophages: implications for pathogenesis. J Infect Dis 2014, 209:1331-1342.
139. Niemeyer D., Zillinger T., Muth D., Zielecki F., Horvath G., Suliman T., et al. Middle East respiratory syndrome coronavirus accessory protein 4a is a type I interferon antagonist. J Virol 2013, 87:12489-12495.
140. Siu K.-L., Yeung M., Kok K.-H., Yuen K.-S., Kew C., Lui P.-Y., et al. Middle East respiratory syndrome coronavirus 4a protein is a double-stranded RNA-binding protein that suppresses PACT-induced activation of RIG-I and MDA5 in the innate antiviral response. J Virol 2014, 88:4866-4876.
141. Siu K.-L., Kok K.-H., Ng M.-H.J., Poon V., Yuen K.-Y., Zheng B.-J., et al. Severe acute respiratory syndrome coronavirus M protein inhibits type I interferon production by impeding the formation of TRAF3.TANK.TBK1/IKKepsilon complex. J Biol Chem 2009, 284:16202-16209.
142. Freundt E., Yu L., Park E., Lenardo M., Xu X.-N. Molecular determinants for subcellular localization of the severe acute respiratory syndrome coronavirus open reading frame 3b protein. J Virol 2009, 83:6631-6640.
143. Kopecky-Bromberg S., Martínez-Sobrido L., Frieman M., Baric R., Palese P. Severe acute respiratory syndrome coronavirus open reading frame (ORF) 3b, ORF 6, and nucleocapsid proteins function as interferon antagonists. J Virol 2007, 81:548-557.
144. Fehling S., Lennartz F., Strecker T. Multifunctional nature of the arenavirus RING finger protein Z. Viruses 2012, 4:2973-3011.
145. Wang J., Danzy S., Kumar N., Ly H., Liang Y. Biological roles and functional mechanisms of arenavirus Z protein in viral replication. J Virol 2012, 86:9794-9801.
146. Fan L., Briese T., Lipkin W. Z proteins of New World arenaviruses bind RIG-I and interfere with type I interferon induction. J Virol 2010, 84:1785-1791.
147. Bao X., Kolli D., Ren J., Liu T., Garofalo R., Casola A. Human metapneumovirus glycoprotein G disrupts mitochondrial signaling in airway epithelial cells. PLoS One 2013, 8.
148. Bao X., Liu T., Shan Y., Li K., Garofalo R., Casola A. Human metapneumovirus glycoprotein G inhibits innate immune responses. PLoS Pathog 2008, 4.
149. Lifland A.W., Jung J., Alonas E., Zurla C., Crowe J.E., Santangelo P.J. Human respiratory syncytial virus nucleoprotein and inclusion bodies antagonize the innate immune response mediated by MDA5 and MAVS. J Virol 2012, 86.
150. Barik S. Respiratory syncytial virus mechanisms to interfere with type 1 interferons. Curr Top Microbiol Immunol 2013, 372:173-191.
151. Goswami R., Majumdar T., Dhar J., Chattopadhyay S., Bandyopadhyay S., Verbovetskaya V., et al. Viral degradasome hijacks mitochondria to suppress innate immunity. Cell Res 2013, 23:1025-1042.
152. Li X.-D., Sun L., Seth R., Pineda G., Chen Z. Hepatitis C virus protease NS3/4A cleaves mitochondrial antiviral signaling protein off the mitochondria to evade innate immunity. Proc Natl Acad Sci USA 2005, 102:17717-17722.
153. Chen Z., Benureau Y., Rijnbrand R., Yi J., Wang T., Warter L., et al. GB virus B disrupts RIG-I signaling by NS3/4A-mediated cleavage of the adaptor protein MAVS. J Virol 2007, 81:964-976.
154. Brack K., Berk I., Magulski T., Lederer J., Dotzauer A., Vallbracht A. Hepatitis A virus inhibits cellular antiviral defense mechanisms induced by double-stranded RNA. J Virol 2002, 76:11920-11930.
155. Fensterl V., Grotheer D., Berk I., Schlemminger S., Vallbracht A., Dotzauer A. Hepatitis A virus suppresses RIG-I-mediated IRF-3 activation to block induction of beta interferon. J Virol 2005, 79:10968-10977.
156. Yang Y., Liang Y., Qu L., Chen Z., Yi M., Li K., et al. Disruption of innate immunity due to mitochondrial targeting of a picornaviral protease precursor. Proc Natl Acad Sci USA 2007, 104:7253-7258.
157. Kovacsovics M., Martinon F., Micheau O., Bodmer J., Hofmann K., Tschopp J. Overexpression of Helicard, a CARD-containing helicase cleaved during apoptosis, accelerates DNA degradation. Curr Biol: CB 2002, 12:838-843.
158. Barral P., Morrison J., Drahos J., Gupta P., Sarkar D., Fisher P., et al. MDA-5 is cleaved in poliovirus-infected cells. J Virol 2007, 81:3677-3684.
159. Barral P., Sarkar D., Fisher P., Racaniello V. RIG-I is cleaved during picornavirus infection. Virology 2009, 391:171-176.
160. Drahos J., Racaniello V. Cleavage of IPS-1 in cells infected with human rhinovirus. J Virol 2009, 83:11581-11587.
161. Wang B., Xi X., Lei X., Zhang X., Cui S., Wang J., et al. Enterovirus 71 protease 2Apro targets MAVS to inhibit anti-viral type I interferon responses. PLoS Pathog 2013, 9.
162. Kuo R.-L., Kao L.-T., Lin S.-J., Wang R., Shih S.-R. MDA5 plays a crucial role in enterovirus 71 RNA-mediated IRF3 activation. PLoS One 2013, 8.
163. Feng Q., Langereis M., Lork M., Nguyen M., Hato S., Lanke K., et al. Enterovirus 2Apro targets MDA5 and MAVS in infected cells. J Virol 2014, 88:3369-3378.
164. Davis M.E., Wang M.K., Rennick L.J., Full F., Mesman A.W., Gringhuis S.I., et al. Antagonism of the Phosphatase PP1 by the Measles Virus V Protein Is Required for Innate Immune Escape of MDA5. Cell Host & Microbe 2014, 10.1015/j.chom.2014.06.007.